US Bancorp

USB remains in a Stage 2 advancing phase above its rising 200-day SMA, preserving a medium-term bullish bias, but the short-term EMAs have crossed lower and price closed below the 9- and 20-day EMAs, indicating unfavorable timing. We will defer execution, stalking for a pullback into the EMA cluster or a decisive reclaim of the short-term EMAs before engaging.

• ↑Record Q2 revenue of $7.71B (+10.1% YoY) and net income of $2.18B (+20%)
• ↑Projected EPS growth of ~13% for fiscal 2026
• ↓Current price ~$64.21 vs fair value ~$58.09 implies ~10% overvaluation